COBACTAN LA 7.5% w/v suspension for injection for cattle
COBACTAN LA 7.5% w/v suspension for injection for cattle
Authorised
- Cefquinome sulfate
Product identification
Medicine name:
COBACTAN LA 7.5% w/v suspension for injection for cattle
Active substance:
- Cefquinome sulfate
Target species:
-
Cattle
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Cefquinome sulfate88.90/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Cattle
-
Meat and offal13day
-
Milkno withdrawal periodDo not use in dairy cows producing milk for human consumption (during lactation or the dry period). Do not use within two months prior to first calving in heifers intended for the production of milk for human consumption.
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01DE90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Package description:
- (ID1) 100 millilitre(s): unspecified outer container with 1 Vial (glass) with 100 millilitre(s)
- (ID2) 250 millilitre(s): unspecified outer container with 1 Vial (glass) with 250 millilitre(s)
- (ID3) 50 millilitre(s): unspecified outer container with 1 Vial (glass) with 50 millilitre(s)
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Intervet International GmbH
- Intervet Productions S.r.l.
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 31352/16-05-2012/K-0094206
Date of authorisation status change:
Reference member state:
-
Germany
Procedure number:
- DE/V/0145/001
Concerned member states:
-
Austria
-
Belgium
-
Cyprus
-
Czechia
-
Denmark
-
France
-
Greece
-
Hungary
-
Italy
-
Luxembourg
-
Netherlands
-
Poland
-
Portugal
-
Slovakia
-
Slovenia
-
Spain
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Greek (PDF)
Published on: 6/03/2025
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Greek (PDF)
Published on: 6/03/2025
